DEA Removing Samidorphan From Controlled Substances List
The Drug Enforcement Administration is removing samidorphan from schedule II of the Controlled Substances Act, it said in a final rule released April 16. DEA said the drug has no abuse potential. The removal eliminates “regulatory controls and administrative, civil,…
Sign up for a free preview to unlock the rest of this article
Export Compliance Daily combines U.S. export control news, foreign border import regulation and policy developments into a single daily information service that reliably informs its trade professional readers about important current issues affecting their operations.
and criminal sanctions applicable to controlled substances, including those specific to schedule II controlled substances, on persons who handle (manufacture, distribute, reverse distribute, dispense, conduct research, import, export, or conduct chemical analysis) or propose to handle samidorphan,” the DEA said. The delisting is effective April 19.